Cargando…

Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways

BACKGROUND: To determine the protein expression profile (PEP) of primary and recurrent ovarian cancer patients in order to predict therapeutic targets for chemotherapy. METHODS: Tissue samples were submitted for PEP in two formats, including formalin-fixed paraffin-embedded tissue for immunohistoche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foss, Cassandra D, Dalton, Heather J, Monk, Bradley J, Chase, Dana M, Farley, John H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877732/ https://www.ncbi.nlm.nih.gov/pubmed/27231557 http://dx.doi.org/10.1186/2053-6844-1-4

Ejemplares similares

Updates on drug discovery in ovarian cancer
por: Gibson, Steven J, et al.
Publicado: (2014)

Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study
por: Minion, Lindsey E., et al.
Publicado: (2016)

Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer
por: Zhang, Xiaojie, et al.
Publicado: (2022)

Profile of olaparib in the treatment of advanced ovarian cancer
por: Chase, Dana M, et al.
Publicado: (2016)

The Prognostic Value of the Apoptosis Pathway in Colorectal Cancer: A Review of the Literature on Biomarkers Identified by Immunohistochemistry
por: Zeestraten, Eliane C.M., et al.
Publicado: (2013)

Global Protein Profiling in Processed Immunohistochemistry Tissue Sections
por: Venz, Simone, et al.
Publicado: (2023)

Immunohistochemistry
por: HAWES, DEBRA, et al.
Publicado: (2009)

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials
por: Friedlander, Michael L., et al.
Publicado: (2016)

Hereditary Risk Evaluation for Borderline Ovarian Tumors Based on Immunohistochemistry
por: Park, Jung Min, et al.
Publicado: (2014)

Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
por: van der Ploeg, Phyllis, et al.
Publicado: (2021)

Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry
por: Wen, Pingwu, et al.
Publicado: (2022)

Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

Apoptosis and apoptotic pathway in actinic prurigo by immunohistochemistry
por: Cuevas-González, Juan-Carlos, et al.
Publicado: (2016)

Perimenopausal Ovarian Carcinoma Patient with Subclavian Node Metastasis Proven by Immunohistochemistry
por: Jeong, Hee Jeong, et al.
Publicado: (2014)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
por: Manchana, Tarinee, et al.
Publicado: (2020)

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
por: Genestie, Catherine, et al.
Publicado: (2019)

Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers
por: Atallah, Ghofraan Abdulsalam, et al.
Publicado: (2023)

Metabolomic Profiling of Poor Ovarian Response Identifies Potential Predictive Biomarkers
por: Song, Haixia, et al.
Publicado: (2021)

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
por: Henzen-Logmans, S. C., et al.
Publicado: (1992)

The Use of Bromodeoxyuridine-Immunohistochemistry to Identify Transplanted Fetal Brain Tissue
por: Brown, Darlene B., et al.
Publicado: (1989)

Use of SDHB immunohistochemistry to identify germline mutations of SDH genes
por: Gill, AJ
Publicado: (2012)

Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

Ovarian Cancer: Current Treatment and Patient Management
por: Monk, Bradley J., et al.
Publicado: (2016)

Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer
por: Yu, Yue, et al.
Publicado: (2019)

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease
por: Arend, Rebecca C., et al.
Publicado: (2021)

Dorsal horn-enriched genes identified by DNA microarray, in situ hybridization and immunohistochemistry
por: Sun, Hong, et al.
Publicado: (2002)

Integrative network analysis identifies potential targets and drugs for ovarian cancer
por: Zhang, Tianyu, et al.
Publicado: (2020)

Cell-blocks and immunohistochemistry
por: Shidham, Vinod B., et al.
Publicado: (2021)

Sequential Immunofluorescence and Immunohistochemistry on Cryosectioned Zebrafish Embryos
por: Ferguson, Jordan L., et al.
Publicado: (2019)

Multiplex immunohistochemistry for immune profiling of HPV-associated head and neck cancer
por: Tsujikawa, Takahiro, et al.
Publicado: (2015)

Applications of immunohistochemistry
por: Duraiyan, Jeyapradha, et al.
Publicado: (2012)

Modern immunohistochemistry
por: Chu, Peiguo G.
Publicado: (2009)

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
por: Köbel, Martin, et al.
Publicado: (2016)

p53 Immunohistochemistry and Mutation Types Mismatching in High-Grade Serous Ovarian Cancer
por: Park, Eunhyang, et al.
Publicado: (2022)

Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets
por: Romani, Chiara, et al.
Publicado: (2021)

HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry
por: Zheng, Qiaoli, et al.
Publicado: (2021)

Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry
por: Jeong, Soo Young, et al.
Publicado: (2021)

Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?
por: Herzog, Thomas J., et al.
Publicado: (2017)

Mast Cells and Blood Vessels Profile in Oral Carcinogenesis: An Immunohistochemistry Study
por: Teófilo, Carolina Rodrigues, et al.
Publicado: (2020)

Protein expression profiling identifies a prognostic model for ovarian cancer
por: Xiong, Luyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umdniumjmh8cok4qn15p2ees43